Related Experiment Video
Updated: May 19, 2026

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
Screening of candidate genes for primary open angle glaucoma
1Department of Ophthalmology, Daping Hospital, Research Institute of Surgery, Third Military Medical University of PLA, Chongqing, China.
Molecular Vision
|August 10, 2012
Summary
Researchers identified potential genes linked to primary open-angle glaucoma (POAG). Genes like FBXO11, VRK2, MSH2, RTN4, and CALM2 may contribute to POAG pathogenesis, offering new insights into this blinding disease.
Area of Science:
- Genetics and Ophthalmology
- Molecular Biology
- Disease Pathogenesis
Background:
- Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness globally.
- Identifying novel genes implicated in POAG is crucial for advancing our understanding and developing therapeutic strategies.
Purpose of the Study:
- To identify novel genes associated with the pathogenesis of primary open-angle glaucoma (POAG).
- To investigate the potential roles of candidate genes in cellular processes relevant to POAG.
Main Methods:
- Haplotype analysis was employed to localize a mutational region to chromosome 2 in affected families.
- Protein-protein interaction (PPI) analysis was used to screen 11 candidate genes on chromosome 2.
- Candidate genes included MSH6, MSH2, REL, EPAS1, VRK2, FBXO11, EFEMP1, RTN4, RAB1A, ACTR2, and CALM2.
Main Results:
- FBXO11 and VRK2 may regulate mitochondrial function and apoptosis through interaction with tumor protein p53.
- MSH2 and RTN4 are implicated in DNA repair and neuronal regeneration, potentially playing a negative role in POAG cellular processes.
- CALM2 may contribute to retinal ganglion cell death and oxidative damage, impacting cellular communication.
Conclusions:
- The study suggests that FBXO11, VRK2, MSH2, RTN4, and CALM2 are potentially associated with the pathogenesis of POAG.
- These findings provide a foundation for further research into the molecular mechanisms underlying POAG.
- Identifying these genes advances the understanding of POAG etiology and may guide future diagnostic and therapeutic developments.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
